HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Infection in Children with Acute Myeloid Leukemia in the Intensive Chemotherapy Period].

AbstractOBJECTIVE:
To investigate the clinical characteristics of infection in children with acute myeloid leukemia (AML) after high intensive chemotherapy, so as to provide reference for prevention and control of infection.
METHODS:
56 children diagnosed as acute myeloid leukemia in our hospital from January 2016 to August 2019 were enrolled and retrospectively analyzed, the infection rate, pathogens of disease and common location of infection during the induction and consolidation period were analyzed.
RESULTS:
The total infection rate of the patients was 93.4%-96.4%, the average of serious infection rate was 16.0%(11.3%-19.6%), and the infection related mortality was 10.7%. Fever of unknown cause was the main reason of infection, while blood flow infections were the most common in severe infection, which were mainly caused by Gramnegative bacteria. The rate of fungal infection was 35.7% during chemotherapy.
CONCLUSION:
Children with AML shows a high incidence of infection in each stage of chemotherapy. The serious illness caused by blood flow infection and take antifungal drugs to reduce the occurrence of fungal infection in AML patients should be paid attention.
AuthorsKai Lan Chen, Hao Xiong, Jian Xin Li, Fang Tao, Bing Wu, Zhuo Wang, Ying Ming Nie, Hui Li
JournalZhongguo shi yan xue ye xue za zhi (Zhongguo Shi Yan Xue Ye Xue Za Zhi) Vol. 29 Issue 5 Pg. 1649-1653 (Oct 2021) ISSN: 1009-2137 [Print] China
PMID34627455 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
Topics
  • Antifungal Agents (therapeutic use)
  • Child
  • Fever (drug therapy)
  • Humans
  • Leukemia, Myeloid, Acute (drug therapy)
  • Mycoses (drug therapy)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: